Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,347.60
(
-0.03%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.73
(
-0.69%
)
Bitcoin
76,894.81
(
-0.66%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bio_pete post# 9105

Thursday, 06/14/2012 11:49:03 AM

Thursday, June 14, 2012 11:49:03 AM

Post# of 20689
Teva’s own PR on thrice-weekly Copaxone:

#msg-76611659

Note that the comparator in the GALA study was placebo, not the regular formulation of Copaxone.

Please see #msg-76610683 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote